Status:
UNKNOWN
Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Conditions:
Hemorrhage From Placenta Previa, With Delivery
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Prophylactic tranexamic acid will reduce blood loss during Caesarean section for placenta praevia
Detailed Description
Tranexamic acid is a promising agent, easy to administer, cheap, and can be added to the other routine management in hospitals deliveries. This study aims to document the efficacy of intravenous trane...
Eligibility Criteria
Inclusion
- all placenta previa major pregnant women
Exclusion
- Any cardiac disorder or liver disease
- Patient on anticoagulant therapy
- History of allergy to tranexamic acid
- Any contraindication for tranexamic acid
Key Trial Info
Start Date :
March 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 23 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04350645
Start Date
March 24 2020
End Date
December 23 2021
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiti Kebangsaan Malaysia Medical Centre
Kuala Lumpur, Malaysia, 56000